The Usefulness of ETDQ ‐7 Score in Assessing ETD
Clinical Otolaryngology · 2025
DOI: 10.1111/coa.14324 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Otolaryngology, 2025. Verfasst von Niels Højvang Holm und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Gødstrup Hospital, Herning, Denmark. Hauptthemen laut MEDLINE: Ear Diseases, Eustachian Tube. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
The ETDQ‐7 questionnaire has been validated for diagnosing Eustachian tube dysfunction (ETD) and a minimal clinically important difference (MCID) of > 3.5 has been suggested. We aim to assess the use of ETDQ‐7 for assessing ETD and a potential correlation between ETDQ‐7 and the Sino‐Nasal Outcome Test 22 (SNOT‐22).
Methods
ETD was based on relevant ear symptoms and objective signs of negative middle ear pressure in 75 consecutive adult patients. Ventilation tube insertion (VTi) was performed on affected ears. ETDQ‐7 and SNOT‐22 scores before and 1 month after VTi were compared to 75 healthy controls.
Results
Mean ETDQ‐7 score decreased from 31.9 to 15.8 ( p < 0.0001), remained stable on unaffected ears, and was 9.6 in controls. MCID was achieved on all affected ears after VTi. A cut‐off score of > 14.5 for diagnosing ETD yielded 100% sensitivity and 94.2% specificity for ETDQ‐7. Spearman's ρ for total score test–retest was 0.878 ( p = 0.000). Cronbach alpha for total score varied from 0.6807 to 0.7266. SNOT‐22 and ETDQ‐7 were correlated at baseline (0.12, p = 0.012). ETD patients scored significantly higher in the nasal, otologic and sleep domains in SNOT‐22 compared to controls.
Conclusion
ETDQ‐7 is a very valid tool for ETD diagnostics and assessing the ear‐related effects of VTi. ETDQ‐7 scores reveal residual symptoms after VTi, indicating symptom relief but no cure for the underlying pathophysiology. For future investigation, we suggest assessing ETDQ‐7 scores for each ear separately, higher MCID values, and integration of quality of life measures. Trial Registration: ClinicalTrials.gov : NCT05055115
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, Gødstrup Hospital, Herning, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Niels Højvang Holm, Therese Ovesen
Zitieren
APA
Holm, N. H., & Ovesen, T. (2025). The Usefulness of ETDQ ‐7 Score in Assessing ETD. Clinical Otolaryngology. https://doi.org/10.1111/coa.14324
Vancouver
Holm NH, Ovesen T. The Usefulness of ETDQ ‐7 Score in Assessing ETD. Clinical Otolaryngology. 2025. doi:10.1111/coa.14324
BibTeX
@article{Holm2025,
author = {Holm, Niels Højvang and Ovesen, Therese},
title = {The Usefulness of ETDQ ‐7 Score in Assessing ETD},
journal = {Clinical Otolaryngology},
year = {2025},
doi = {10.1111/coa.14324}
}
EUVIMED